Skip to main content
Retour
Watch Compare

CITIUS ONCOLOGY, INC.

Qualité des données : 83%
CTOR
Nasdaq Manufacturing Chemicals
0,66 €
▲ 0,02 € (2,79%)
Cap. Boursière: 58,27 M
Prix
0,66 €
Cap. Boursière
58,27 M
Fourchette du Jour
0,62 € — 0,67 €
Fourchette 52 Semaines
0,49 € — 6,19 €
Volume
80 221
Ouverture 0,63 €
Moyenne 50J / 200J
0,96 €
30,94% below
Moyenne 50J / 200J
1,59 €
58,51% below

Quick Summary

Points Clés

Negative free cash flow of -12,85 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-52,06%
En dessous de la moyenne du secteur (-51,02%)
ROIC-43,72%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,83
Interest Coverage-109,05

Valorisation

PE (TTM)
-2,47
En dessous de la moyenne du secteur (-1,98)
P/B Ratio1,00
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -2,5 -2,0
P/B 1,0 5,1
ROE % -52,1 -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -23,64 M
ROE -52,06% ROA -23,44%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -12,85 M
ROIC -43,72% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,83
Interest Coverage -109,05 Asset Turnover N/A
Working Capital -7,56 M Tangible Book Value 58,41 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,47 Forward P/E N/A
P/B Ratio 1,00 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -22,05%
Market Cap 58,27 M Enterprise Value 50,98 M
Per Share
EPS (Diluted TTM) -0,31 Revenue / Share N/A
FCF / Share -0,15 OCF / Share -0,15
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 54,35%
SBC-Adj. FCF -22,83 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue — — — —
Net Income -24,76 M -21,15 M 2,42 M 380 811,0
EPS (Diluted) -0,34 -0,31 0,27 0,12
Gross Profit — — — —
Operating Income -23,52 M — -1,01 M -138 115,0
EBITDA — — — —
R&D Expenses 6,42 M 4,93 M — —
SG&A Expenses — — — —
D&A — — — —
Interest Expense 218 032,0 — — —
Income Tax 1,06 M 576 000,0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 100,94 M 84,37 M 72,62 M 68,19 M
Total Liabilities 56,08 M 38,23 M — —
Shareholders' Equity 44,87 M 46,14 M -1,99 M 345 508,0
Total Debt — — — —
Cash & Equivalents — — — —
Current Assets 27,54 M 10,97 M 58 200,0 377 344,0
Current Liabilities 49,49 M 32,70 M 2,05 M 31 836,0